Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HHS BARDA
Manufacturing
GSK, Sanofi, CSL nab BARDA funding for bird flu shots
CSL Seqirus, Sanofi and GSK have collectively secured $72 million in BARDA funding to boost U.S. supply of bird flu vaccines.
Angus Liu
Oct 4, 2024 1:35pm
CSL Seqirus picks up its 5th bird-flu-related BARDA award
Sep 26, 2024 3:50pm
US bulks up supply of Amgen's radiation sickness med Nplate
Oct 5, 2022 11:09am
HHS taps Marinus Pharma to produce API for anti-seizure drug
Sep 22, 2022 9:40am
HHS earmarks $680M for smallpox drug, an Emergent buyout target
Aug 29, 2022 11:50am
Seqirus completes $156M expansion at fill-finish plant
Jun 9, 2022 9:35am
